Viridian Therapeutics
VRDN
#4812
Rank
S$2.04 B
Marketcap
$25.80
Share price
-9.08%
Change (1 day)
-8.08%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -$6.61

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.64. In 2022 the company made an earnings per share (EPS) of -$5.49 an increase over its 2021 EPS that were of -$10.33.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.6120.29%
2022-$5.49-46.83%
2021-$10.33-73.94%
2020-$39.6444.73%
2019-$27.3922.94%
2018-$22.28-27.33%
2017-$30.66-91.47%
2016-$359.36-19.17%
2015-$444.60-75.48%
2014-$1,813582.47%
2013-$265.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.97-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA